You are here: Home Published Research Safety and immunogenicity of an investigational vaccine containing two common pneumococcal proteins in toddlers: a phase II randomized clinical trial.

Roman Prymula, Petr Pazdiora, Magali Traskine, Jens U R├╝ggeberg, and Dorota Borys (2014)

Safety and immunogenicity of an investigational vaccine containing two common pneumococcal proteins in toddlers: a phase II randomized clinical trial.

Vaccine, 32(25):3025–3034.

To provide broader protection against pneumococcal disease, new vaccines containing conserved Streptococcus pneumoniae proteins are being developed. This study assessed the safety, reactogenicity and immunogenicity of four formulations containing pneumococcal proteins pneumolysin toxoid (dPly) and histidine triad protein (PhtD) in toddlers.

Antibodies, Bacterial, Bacterial Proteins, Czech Republic, Drugs, Investigational, Female, Humans, Hydrolases, Immunization, Secondary, Infant, Male, Pneumococcal Vaccines, Streptolysins, Vaccines, Conjugate
Antibodies, Bacterial, Bacterial Proteins, Czech Republic, Drugs, Investigational, Female, Humans, Hydrolases, Immunization, Secondary, Infant, Male, Pneumococcal Vaccines, Streptolysins, Vaccines, Conjugate
 
Document Actions